New 5-in-1 Pediatric Vaccine Reduces Shots
Posted on: Tuesday, 24 June 2008, 02:30 CDT
The U.S. Food and Drug Administration has licensed a vaccine against five childhood ailments in a single dose, officials at Sanofi Pasteur said.
The first 5-in-1 pediatric combination vaccine -- approved for use in infants and children 6 weeks through 4 years of age -- contains immunization against invasive disease due to Haemophilus influenza type b, diphtheria, tetanus, pertussis and poliomyelitis.
Pentacel vaccine is approved for administration as a four-dose series at 2, 4, 6 and 15 to 18 months of age. The first dose may be given as early as 6 weeks of age.
The current recommended childhood immunization schedule of the U.S. Centers for Disease Control and Prevention in Atlanta says up to 23 injections are needed by the time a child reaches 18 months of age with single-entity vaccines, however, the use of the Pentacel vaccine could reduce that number of shots by seven, said Wayne Pisano, president and chief executive officer of Sanofi Pasteur.
Pisano said the current recommended childhood immunization schedule of the U.S. Centers for Disease Control and Prevention in Atlanta says up to 23 injections are needed by the time a child reaches 18 months of age with single-entity vaccines.
However the use of the Pentacel vaccine -- already approved in Canada for a decade -- could reduce that number of shots by seven.
Source: United Press International
Related Articles
- Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
- Nasal Hepatitis B Vaccine Elicits Robust Immunity With a Single Dose
- Single Dose Pandemic Vaccine Effective
- Knopp Neurosciences Presents Results of Phase 1 Ascending Single-Dose Study of KNS-760704
- Vaccine Against Children Diarrhea Wins FDA Approval
- FDA Approves Expanded Age Indication for VAQTA(R) (Hepatitis A Vaccine, Inactivated), Merck's Hepatitis A Vaccine, to Children As Young As 12 Months of Age
- Single-Dose Antibiotic Approved
- Pfizer's Single-Dose Antibiotic Zmax(Tm) Receives FDA Approval; Over 36M Prescribed Antibiotics for Sinusitis, Pneumonia in 2004(1)
- Clinical Pharmacokinetics of Lyophilized Recombinant Human Erythropoietin-[Alpha] Following Single-Dose Subcutaneous Administration in Premature Newborns
- The Analgesic Effect of Etoricoxib Relative to That of Two Opioid- Acetaminophen Analgesics: a Randomized, Controlled Single-Dose Study in Acute Dental Impaction Pain*
 |
 |
User Comments (0)
RSS Feeds